Therapeutic Solutions International Overview

  • Founded
  • 2007
Founded
  • Status
  • Public
  • Employees
  • 4
Employees
  • Stock Symbol
  • TSOI
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $0.06
  • (As of Friday Closing)

Therapeutic Solutions International General Information

Description

Therapeutic Solutions International Inc focuses on immune modulation for the treatment of several specific diseases. It is engaged in developing a range of immune-modulatory agents to target certain cancers, improve maternal and fetal health, fight periodontal disease, and for daily health. The business divisions of the company are Nutraceutical Division which produces ProJuvenol, a synergistic blend of complex anti-aging ingredients to help promote cellular rejuvenation and healthy functionality, Emvolio, Inc which develops products that can be used together to attack cancer as different levels, and sandbox dental labs, Inc consists of dental laboratory to manufacture and fill prescriptions from dentist.

Contact Information

Formerly Known As
Friendly Auto Dealers Inc
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Stock Exchange
PINX
Primary Office
  • 701 Wild Rose Lane
  • Elk City, ID 83525
  • United States
+1 (760) 000-0000

Therapeutic Solutions International Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Therapeutic Solutions International Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.06 $0.06 $146M 2.26B 14.4M

Therapeutic Solutions International Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 94,330 14,918 5,260 5,840
Revenue 74 63 27 3
EBITDA (1,735) (1,890) (1,340) (1,625)
Net Income (2,167) (2,200) (1,697) (1,867)
Total Assets 826 603 311 207
Total Debt 1,055 1,040 982 504
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Therapeutic Solutions International Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Therapeutic Solutions International‘s full profile, request access.

Request a free trial

Therapeutic Solutions International Executive Team (5)

Name Title Board Seat Contact Info
Timothy Dixon Chairman, President & Chief Executive Officer
Gerry Berg Vice President, Chief Financial Officer, Secretary & Board Member
Feng Lin MD Chief Scientific Officer
James Veltmeyer MD Chief Medical Officer
You’re viewing 4 of 5 executive team members. Get the full list »

Therapeutic Solutions International Board Members (1)

Name Representing Role Since
0000000 00000 Therapeutic Solutions International Chairman, President & Chief Executive Officer 000 0000
To view Therapeutic Solutions International’s complete board members history, request access »

Therapeutic Solutions International Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Therapeutic Solutions International Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Therapeutic Solutions International‘s full profile, request access.

Request a free trial

Therapeutic Solutions International Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 000000 10-Feb-2021 000000000 00000 00 Buildings and Property 0000000 00000
Splint Decisions 04-Apr-2011 Merger/Acquisition Clinics/Outpatient Services 00000 0000
To view Therapeutic Solutions International’s complete investments and acquisitions history, request access »